A treatment that genetically alters a patient’s own immune cells to fight cancer has, for the first time, produced remissions in adults with a deadly type of acute leukemia that resisted chemotherapy and left little hope of survival, researchers are reporting.
In one patient who was severely ill, all traces of leukemia vanished in eight days.
While it’s far from a cure, the new T-cell treatment successfully sent several patients leukemia into remission for periods ranging from a few months to two years. Currently, only 40 percent of adults diagnosed with acute leukemia survive the disease, though the rate is now much higher among children (80-90%).
March 20, 2013 // 16:12 // 1 year ago